Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Alcohol and arrhythmiasCardiologia Hungarica (Budapest), 2024-02, Vol.54 (1), p.48-52ISSN: 0133-5596 ;EISSN: 1588-0230 ;DOI: 10.26430/CHUNGARICA.2024.54.1.48Full text available |
|
2 |
Material Type: Newspaper Article
|
An NIH genetics study targets a long-standing challenge: Diversity: Nearly half the DNA samples in the “All of Us” program are from racial or ethnic minorities. But many biomedical research projects still routinely struggle to attract non-White participantsThe Washington post (Washington, D.C. 1974. Online), 2024-05-07Copyright WP Company LLC d/b/a The Washington Post May 7, 2024 ;ISSN: 0190-8286 ;EISSN: 2641-9599Full text available |
|
3 |
Material Type: Newsletter Article
|
Applied Therapeutics (APLT: $4.75) accelerates rise, up 7.0% in 2 days; +31c [7.0%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 4, 2024Digital Resources/Online E-Resources |
|
4 |
Material Type: Newsletter Article
|
Applied Therapeutics (APLT: $4.86) climbs 2.1% strengthening above moving average price; +10c [2.1%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 7, 2024Digital Resources/Online E-Resources |
|
5 |
Material Type: Newsletter Article
|
Cardiovascular Imaging Journal Issues Research Articles in May 1, 2024 EditionTargeted News Service, 2024Targeted News ServiceDigital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Clinical application of paediatric serum troponin T testingArchives of disease in childhood, 2024-05, p.archdischild-2023-326719 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-9888 ;EISSN: 1468-2044 ;DOI: 10.1136/archdischild-2023-326719Full text available |
|
7 |
Material Type: Newsletter Article
|
Clinical Trial: Assessment of Cardiac Function, Microvascular Function and Cardiac Perfusion in Different Disease Stages of Hypertrophic CardiomyopathyUS Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited May 6, 2024Digital Resources/Online E-Resources |
|
8 |
Material Type: Newsletter Article
|
Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results Company UpdatePR Newswire, 2024Copyright PR Newswire Association LLC May 7, 2024Digital Resources/Online E-Resources |
|
9 |
Material Type: Newsletter Article
|
Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)Business Wire, 2024Copyright Business Wire 2024Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Effects of trimetazidine on heart failure with reduced ejection fraction and associated clinical outcomes: a systematic review and meta-analysisOpen heart, 2024-05, Vol.11 (1) [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2023-002579Full text available |
|
11 |
Material Type: Reports
|
Heart arrhythmiaMayo Clinic Health Information Library : Diseases and Conditions, 20242024 Mayo Foundation for Medical Education and Research (MRMER). All rights reserved.Digital Resources/Online E-Resources |
|
12 |
Material Type: Reports
|
Heart diseaseMayo Clinic Health Information Library : Diseases and Conditions, 20242024 Mayo Foundation for Medical Education and Research (MRMER). All rights reserved.Digital Resources/Online E-Resources |
|
13 |
Material Type: Reports
|
Heart diseaseMayo Clinic Health Information Library : Diseases and Conditions, 20242024 Mayo Foundation for Medical Education and Research (MRMER). All rights reserved.Digital Resources/Online E-Resources |
|
14 |
Material Type: Newsletter Article
|
Heart Failure Journal Issues Research Articles in May 1, 2024 EditionTargeted News Service, 2024Targeted News ServiceDigital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Impact of androgenic anabolic steroid use on cardiovascular and mental health in Danish recreational athletes: protocol for a nationwide cross-sectional cohort study as a part of the Fitness Doping in Denmark (FIDO-DK) studyBMJ open, 2024-05, Vol.14 (5), p.e078558 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-078558Full text available |
|
16 |
Material Type: Article
|
Incidence and Impact of Takotsubo Syndrome in Hospitalized Patients With COVID-19Texas Heart Institute journal, 2024-05, Vol.51 (1), p.1-10 [Peer Reviewed Journal]2024 The Authors. Published by The Texas Heart Institute®. ;2024 The Authors. Published by The Texas Heart Institute 2024 ;ISSN: 0730-2347 ;EISSN: 1526-6702 ;DOI: 10.14503/THIJ-23-8309 ;PMID: 38708821Full text available |
|
17 |
Material Type: Newsletter Article
|
Intellia Therapeutics (NTLA: $23.60) rises in 4 out of last 5 days, 5-day rise of 14%; +33c [1.4%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 4, 2024Digital Resources/Online E-Resources |
|
18 |
Material Type: Newsletter Article
|
Intellia Therapeutics (NTLA: $23.72) rises in 4 out of last 5 days, 5-day rise of 7.9%; +12c [0.5%]News Bites US - NASDAQ, 2024Copyright News Bites Pty Ltd May 7, 2024Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Ivabradine ameliorates cardiomyopathy progression in a Duchenne muscular dystrophy model ratExperimental animals, 2024-05, Vol.73 (2), p.145EISSN: 1881-7122 ;PMID: 37914289Digital Resources/Online E-Resources |
|
20 |
Material Type: Newsletter Article
|
Journal of the American College of Cardiology Issues Research Articles in May 14, 2024 EditionTargeted News Service, 2024Targeted News ServiceDigital Resources/Online E-Resources |